The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
De novo mutations in schizophrenia implicate synaptic networks
Open accessAbstract
Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one or a few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-d-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While most children with SCN2A variants fit into one of these three categories, there are some exceptions, including epileptic encephalopathy with choreoathetoid movements [26,27], benign infantile seizures with late-onset episodic ataxia [28–31], childhood-onset epileptic encephalopathy [32], and schizophrenia [33,34].”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [33]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The human NDR2 gene (STK38l) has been identified as a susceptibility gene for neurodevelopmental disorders, intellectual disability (Madencioglu et al. 2021; Firth et al. 2009), and autism spectrum disorder (Fromer et al. 2014).”
From The Serine/Threonine Kinase NDR2 Regulates Integrin Signaling, Synapse Formation, and Synaptic Plasticity in the Hippocampus (2025) · cites this paper as Fromer et al. 2014
Experimental — accuracy not yet measuredIn the citing paper
“We tested for and found that genes in which rare variants increase risk of ASD and DD32,33 are also enriched for schizophrenia common variant associations.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“We controlled for a set of 10,360 genes with detectable expression in brain tissue measured as Fragments Per Kilobase of transcript per Million mapped reads (FPKM)32 to detect synaptic signals above signals simply reflecting the property of brain expression.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [80]
In the citing paper
“Protein-truncating variants (PTVs) are among the most interpretable associations as they suggest that the effect on disease most commonly tracks with decreasing expression of the gene18.”
From Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) · cites this paper as [18]
In the citing paper
“This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“A strong and consistent finding in exome-sequencing studies of schizophrenia involves an excess of variants in genes whose mRNAs are bound by the fragile X mental retardation protein (FMRP)9,12,27.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“we identified an ultra-rare splice donor variant in TAF1312, an ultra-rare nonsense variant in SETD1A16,17, and a single ultra-rare nonsense variant in NRXN1, a gene in which exonic deletions associate with schizophrenia18.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia12 and 0.156 (95% CI 0.139-0.174) for unaffected individuals13.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“Estimated 3rd and 5th principal components corresponded to previously observed Finnish and Northern-Southern Sweden clines12 (Supplementary Fig. 12d)”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Rate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Self-citationDiagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,004
Genetics of Schizophrenia: Ready to Translate?
Foley, C., Corvin, A. P., & Nakagome, S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0807-5 · Cited by 61
Soler, J., Fañanás, L., Parellada, M., Krebs, M., Rouleau, G. A., & Fatjó‐Vilas, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170066 · Cited by 61
Khanal, P., & Hotulainen, P. (2021) · Cells · doi:10.3390/cells10092392 · Cited by 60
Genetic research in autism spectrum disorders
Robinson, E. B., Neale, B. M., & Hyman, S. E. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000278 · Cited by 60
Li, J., Zhu, L., Guan, F., Yan, Z., Liu, D., Han, W., & Chen, T. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.005 · Cited by 60
Usp9X Controls Ankyrin-Repeat Domain Protein Homeostasis during Dendritic Spine Development
Yoon, S., Parnell, E., Kasherman, M. A., Forrest, M. P., Myczek, K., Premarathne, S., Vega, M. C., Piper, M., Burne, T. H. J., Jolly, L. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.003 · Cited by 60
Genetics of schizophrenia (Review)
Trifu, S. C., Kohn, B., Vlasie, A., & Patrichi, B. E. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8973 · Cited by 60
The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders
Zhang, K., Wang, Y., Fan, T., Zeng, C., & Sun, Z. S. (2020) · Protein & Cell · doi:10.1007/s13238-020-00812-9 · Cited by 60
Epigenetic Mechanisms of Serotonin Signaling
Holloway, T. D., & González‐Maeso, J. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00033 · Cited by 60
Foote, M. M., Qiao, H., Graham, K., Wu, Y., & Zhou, Y. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.015 · Cited by 60
Balu, D. T., Li, Y., Takagi, S., Presti, K. T., Ramikie, T. S., Rook, J. M., Jones, C. K., Lindsley, C. W., Conn, P. J., Bolshakov, V. Y., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.2 · Cited by 60
Pers, T. H., Timshel, P. N., Ripke, S., Sullivan, P. F., O’Donovan, M. C., Franke, L., & Hirschhorn, J. N. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw007 · Cited by 60
Self-citationWilkerson, J. R., Albanesi, J. P., & Huber, K. M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.035 · Cited by 60
Phenotypic expansion of POGZ‐related intellectual disability syndrome (White‐Sutton syndrome)
Batzir, N. A., Posey, J. E., Song, X., Coban‐Akdemir, Z., Rosenfeld, J. A., Brown, C., Chen, E., Holtrop, S., Mizerik, E. A., Moreno, M. N., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61380 · Cited by 60
Integrin adhesion in brain assembly: From molecular structure to neuropsychiatric disorders
Jaudon, F., Thalhammer, A., & Cingolani, L. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14859 · Cited by 59
NBEA: Developmental disease gene with early generalized epilepsy phenotypes
Mulhern, M., Schrander-Stumpel, C. T. R. M., Stong, N., Brunner, H. G., Bier, L., Lippa, N. C., Riviello, J. J., Rouhl, R. P. W., Kempers, M. J. E., Pfundt, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25350 · Cited by 59
Transcriptomic Insight Into the Polygenic Mechanisms Underlying Psychiatric Disorders
Hernandez, L. M., Kim, M., Hoftman, G. D., Haney, J. R., de la Torre-Ubieta, L., Paşaniuc, B., & Gandal, M. J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.005 · Cited by 59
The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia
Nehme, R., Pietiläinen, O., Artomov, M., Tegtmeyer, M., Valakh, V., Lehtonen, L., Bell, C., Singh, T., Trehan, A., Sherwood, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31436-8 · Cited by 58
Self-citationPersistent memories of long-term potentiation and the N -methyl-d-aspartate receptor
Bliss, T. V. P., & Collingridge, G. L. (2019) · Brain and Neuroscience Advances · doi:10.1177/2398212819848213 · Cited by 58
Global Scientific Outputs of Schizophrenia Publications From 1975 to 2020: a Bibliometric Analysis
Kıraz, S., & Demir, E. (2021) · Psychiatric Quarterly · doi:10.1007/s11126-021-09937-4 · Cited by 58
Whitton, L., Cosgrove, D., Clarkson, C., Harold, D. H., Kendall, K. M., Richards, A. L., Mantripragada, K. K., Owen, M. J., O’Donovan, M. C., Walters, J., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32503 · Cited by 58
Self-citationShohat, S., Ben‐David, E., & Shifman, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.007 · Cited by 58
A genomic lifespan program that reorganises the young adult brain is targeted in schizophrenia
Skene, N., Roy, M. M., & Grant, S. G. N. (2017) · eLife · doi:10.7554/elife.17915 · Cited by 58
Self-citationthe Janssen-CHOP Neuropsychiatric Genomics Working Group, Glessner, J., Li, J., Wang, D., March, M., Lima, L., Desai, A. G., Hadley, D., Kao, C., Gur, R. E., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0494-1 · Cited by 58
Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease
Manoli, D. S., & Tollkühn, J. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13564 · Cited by 58
Rediscovering the value of families for psychiatric genetics research
Glahn, D. C., Nimgaonkar, V. L., Raventós, H., Rojas, J. C., McIntosh, A. M., Thomson, P. A., Jablensky, A. V., McCarthy, N. S., Charlesworth, J., Blackburn, N. B., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0073-x · Cited by 59
Suliman-Lavie, R., Title, B., Cohen, Y., Hamada, N., Tal, M., Tal, N., Monderer‐Rothkoff, G., Gudmundsdottir, B., Gudmundsson, K. O., Keller, J. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19577-0 · Cited by 58
Ankyrins and neurological disease
Stevens, S. R., & Rasband, M. N. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.01.002 · Cited by 58
LIM-Kinases in Synaptic Plasticity, Memory, and Brain Diseases
Zablah, Y. B., Zhang, H., Gugustea, R., & Jia, Z. (2021) · Cells · doi:10.3390/cells10082079 · Cited by 58
Dunlop, J., & Brandon, N. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565806 · Cited by 57
Léna, I., & Mantegazza, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49392-7 · Cited by 57
Topol, A., English, J. A., Flaherty, E. K., Rajarajan, P., Hartley, B. J., Gupta, S., Desland, F. A., Zhu, S., Goff, T., Friedman, L., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.118 · Cited by 57
Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models
Haggarty, S. J., Silva, M. C., Cross, A. J., Brandon, N. J., & Perlis, R. H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.01.011 · Cited by 57
AUTS2 isoforms control neuronal differentiation
Monderer‐Rothkoff, G., Tal, N., Risman, M., Shani, O., Nissim‐Rafinia, M., Malki-Feldman, L., Medvedeva, V. P., Groszer, M., Meshorer, E., & Shifman, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0409-1 · Cited by 57
Peters, B. A., Kermani, B. G., Alferov, O., Agarwal, M. R., McElwain, M. A., Gulbahce, N., Hayden, D. M., Tang, Y. T., Zhang, R. Y., Tearle, R. G., et al. (2015) · Genome Research · doi:10.1101/gr.181255.114 · Cited by 57
Gulchina, Y., Xu, S., Snyder, M. A., Elefant, F., & Gao, W. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14101 · Cited by 56
Roles of the HUWE1 ubiquitin ligase in nervous system development, function and disease
Giles, A. C., & Grill, B. J. (2020) · Neural Development · doi:10.1186/s13064-020-00143-9 · Cited by 56
Zbtb16 regulates social cognitive behaviors and neocortical development
Usui, N., Berto, S., Konishi, A., Kondo, M., Konopka, G., Matsuzaki, H., & Shimada, S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01358-y · Cited by 56
Herborg, F., Andreassen, T. F., Berlin, F., Loland, C. J., & Gether, U. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001753 · Cited by 56
Arc/Arg3.1 mediates a critical period for spatial learning and hippocampal networks
Gao, X., Castro‐Gomez, S., Grendel, J., Graf, S., Süsens, U., Binkle-Ladisch, L., Mensching, D., Isbrandt, D., Kuhl, D., & Ohana, O. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810125115 · Cited by 56
Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01515-3 · Cited by 55
Transgenic labeling of parvalbumin-expressing neurons with tdTomato
Kaiser, T., Ting, J. T., Monteiro, P., & Feng, G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.036 · Cited by 55
Dynamic Control of Synaptic Adhesion and Organizing Molecules in Synaptic Plasticity
Rudenko, G. (2017) · Neural Plasticity · doi:10.1155/2017/6526151 · Cited by 56
Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation
Carroll, L. S., Woolf, R., Ibrahim, Y., Williams, H. J., Dwyer, S., Walters, J., Kirov, G., O’Donovan, M. C., & Owen, M. J. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000110 · Cited by 54
Self-citationNeurological dysfunctions associated with altered BACE 1‐dependent Neuregulin‐1 signaling
Hu, X., Fan, Q., Hou, H., & Yan, R. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13395 · Cited by 54
Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia
John, J., Kukshal, P., Triptish Bhatia, A., Chowdari, K. V., Nimgaonkar, V. L., Deshpande, S. N., & Thelma, B. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.02.020 · Cited by 54
Yuan, A., Veeranna, Sershen, H. W., Basavarajappa, B. S., Smiley, J. F., Hashim, A., Bleiwas, C., Berg, M. J., Guifoyle, D. N., Subbanna, S., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0194-7 · Cited by 54
Sakurai, T., & Gamo, N. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.007 · Cited by 54
Mechanism of IRSp53 inhibition by 14-3-3
Kast, D. J. E., & Domínguez, R. (2019) · Nature Communications · doi:10.1038/s41467-019-08317-8 · Cited by 54
Thinking About Schizophrenia in an Era of Genomic Medicine
Weinberger, D. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18111275 · Cited by 53
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
Lafanéchère, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.969183 · Cited by 53
A critical role of RBM8a in proliferation and differentiation of embryonic neural progenitors
Zou, D., McSweeney, C., Sebastian, A., Reynolds, D. J., Dong, F., Zhou, Y., Deng, D., Wang, Y., Liu, L., Zhu, J., et al. (2015) · Neural Development · doi:10.1186/s13064-015-0045-7 · Cited by 53
Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases
Sundararajan, T., Manzardo, A. M., & Butler, M. G. (2017) · Gene · doi:10.1016/j.gene.2017.10.035 · Cited by 53
Mapping pathologic circuitry in schizophrenia
Glausier, J. R., & Lewis, D. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00025-6 · Cited by 53
Fast genetic mapping of complex traits in C. elegans using millions of individuals in bulk
Burga, A. R., Ben‐David, E., Lemus, T., Boocock, J., & Kruglyak, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10636-9 · Cited by 53
Stevens, S. R., Longley, C. M., Ogawa, Y., Teliska, L. H., Arumanayagam, A. S., Nair, S., Oses-Prieto, J. A., Burlingame, A. L., Cykowski, M. D., Xue, M., et al. (2021) · eLife · doi:10.7554/elife.66491 · Cited by 53
Huentelman, M. J., Muppana, L., Corneveaux, J. J., Dinu, V., Pruzin, J. J., Reiman, R., Borish, C. N., De Both, M., Ahmed, A., Todorov, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135076 · Cited by 52
Arc – An endogenous neuronal retrovirus?
Shepherd, J. D. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.029 · Cited by 52
Rammos, A., Gonzalez, L. A. N., Weinberger, D. R., Mitchell, K. J., & Nicodemus, K. K. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0410-z · Cited by 52
Transcriptional targets of the schizophrenia risk gene MIR137
Collins, A. L., Kim, Y., Bloom, R. J., Kelada, S. N. P., Sethupathy, P., & Sullivan, P. F. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.42 · Cited by 52
Merico, D., Zarrei, M., Costain, G., Ogura, L., Alipanahi, B., Gazzellone, M. J., Butcher, N. J., Thiruvahindrapuram, B., Nalpathamkalam, T., Chow, E. W. C., et al. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.021345 · Cited by 52
Devanna, P., Chen, X., Ho, J., Gajewski, D., Smith, S. D., Gialluisi, A., Francks, C., Fisher, S. E., Newbury, D. F., & Vernes, S. C. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.30 · Cited by 52
Achuta, V. S., Möykkynen, T. P., Peteri, U., Turconi, G., Rivera, C., KEINÄNEN, K. P., & Castrén, M. L. (2018) · Science Signaling · doi:10.1126/scisignal.aan8784 · Cited by 52
MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome
Merico, D., Costain, G., Butcher, N. J., Warnica, W. D., Ogura, L., Alfred, S. E., Brzustowicz, L. M., & Bassett, A. S. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00238 · Cited by 51
What have we learned from the Psychiatric Genomics Consortium
O’Donovan, M. C. (2015) · World Psychiatry · doi:10.1002/wps.20270 · Cited by 51
Self-citationGrannan, M. D., Mielnik, C. A., Moran, S. P., Gould, R. W., Ball, J., Lu, Z., Bubser, M., Ramsey, A. J., Abe, M., Cho, H. P., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00230 · Cited by 51
Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies
Xiao, X., Chang, H., & Li, M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.241 · Cited by 51
Jin, Z., Li, Z., Liu, Z., Jiang, Y. W., Cai, X., & Wu, J. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12383 · Cited by 51
Presentation of TRPM1-Associated Congenital Stationary Night Blindness in Children
Utz, V. M., Pfeifer, W. L., Longmuir, S. Q., Olson, R. J., Wang, K., & Drack, A. V. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.0185 · Cited by 51
Wu, Y., Bi, R., Zeng, C., Ma, C., Sun, C., Li, J., Xiao, X., Li, M., Zhang, D., Zheng, P., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.006 · Cited by 51
Claudio Toma, A., Pierce, K. D., Shaw, A. D., Heath, A., Mitchell, P. B., Schofield, P. R., & Fullerton, J. M. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007535 · Cited by 51
Segura‐Bayona, S., & Stracker, T. H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03208-z · Cited by 52
Metabolic constraints on synaptic learning and memory
Karbowski, J. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00092.2019 · Cited by 51
Large-scale neuroanatomical study uncovers 198 gene associations in mouse brain morphogenesis
Collins, S. C., Mikhaleva, A., Vrcelj, K., Vancollie, V. E., Wagner, C., Demeure, N., Whitley, H., Kannan, M., Balz, R., Anthony, L. F. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11431-2 · Cited by 51
Aller, M. I., Pecoraro, V., Paternain, A. V., Canals, S., & Lerma, J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2217-15.2015 · Cited by 50
Zick, J. L., Blackman, R. K., Crowe, D. A., Amirikian, B., DeNicola, A. L., Netoff, T. I., & Chafee, M. V. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.010 · Cited by 50
Exome arrays capture polygenic rare variant contributions to schizophrenia
Richards, A. L., Leonenko, G., Walters, J. T., Kavanagh, D. H., Rees, E. G., Evans, A., Chambert, K. D., Moran, J. L., Goldstein, J., Neale, B. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv620 · Cited by 50
Self-citationAnimal models of recurrent or bipolar depression
Kato, T., Kasahara, T., Kubota‐Sakashita, M., Kato, T., & Nakajima, K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.016 · Cited by 50
Isidor, B., Küry, S., Rosenfeld, J. A., Besnard, T., Schmitt, S., Joss, S. K., Davies, S. J., Lebel, R. R., Henderson, A., Schaaf, C. P., et al. (2016) · Human Mutation · doi:10.1002/humu.22952 · Cited by 50
Dissecting autism and schizophrenia through neuroimaging genomics
Moreau, C. A., Raznahan, A., Bellec, P., Chakravarty, M. M., Thompson, P. M., & Jacquemont, S. (2021) · Brain · doi:10.1093/brain/awab096 · Cited by 51
Das, S., Lituma, P. J., Castillo, P. E., & Singer, R. H. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.005 · Cited by 49
Molecular mechanisms of schizophrenia: Insights from human genetics
Farsi, Z., & Sheng, M. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102731 · Cited by 49
Biamino, E., Gregorio, E. D., Belligni, E. F., Keller, R., Riberi, E., Gandione, M., Calcia, A., Mancini, C., Giorgio, E., Cavalieri, S., et al. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32406 · Cited by 49
Electrophysiological Endophenotypes for Schizophrenia
Owens, E. M., Bachman, P., Glahn, D. C., & Bearden, C. E. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000110 · Cited by 50
Sobue, A., Kushima, I., Nagai, T., Shan, W., Kohno, T., Aleksić, B., Aoyama, Y., Mori, D., Arioka, Y., Kawano, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31390-w · Cited by 49
Wang, Q., Li, M., Yang, Z., Hu, X., Wu, H.-M., Ni, P., Ren, H., Deng, W., Li, M., Ma, X., et al. (2015) · Scientific Reports · doi:10.1038/srep18209 · Cited by 49
Roles and mechanisms of ankyrin-G in neuropsychiatric disorders
Yoon, S., Piguel, N. H., & Penzes, P. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00798-w · Cited by 48
Stogsdill, J. A., Harwell, C. C., & Goldman, S. A. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15004 · Cited by 49
A case of autism spectrum disorder arising from a de novo missense mutation in POGZ
Fukai, R., Hiraki, Y., Yofune, H., Tsurusaki, Y., Nakashima, M., Saitsu, H., Tanaka, F., Miyake, N., & Matsumoto, N. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.13 · Cited by 48
Specific Roles of NMDA Receptor Subunits in Mental Disorders
Yamamoto, H., Hagino, Y., Kasai, S., & Ikeda, K. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330142807 · Cited by 48
Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders
Lin, M., Lachman, H. M., & Zheng, D. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.009 · Cited by 48
The molecular evolution of the vertebrate behavioural repertoire
Grant, S. G. N. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0051 · Cited by 48
Self-citationMolecular Risk Factors for Schizophrenia
Modai, S., & Shomron, N. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.006 · Cited by 48
Integrated Post-GWAS Analysis Sheds New Light on the Disease Mechanisms of Schizophrenia
Lin, J.-R., Cai, Y., Zhang, Q., Zhang, W., Nogales‐Cadenas, R., & Zhang, Z. D. (2016) · Genetics · doi:10.1534/genetics.116.187195 · Cited by 48
Glycine Transporters and Its Coupling with NMDA Receptors
Zafra, F., Ibáñez, I., Bartolomé‐Martín, D., Piniella, D., Arribas-Blázquez, M., & Giménez, C. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-55769-4_4 · Cited by 48
Reijnders, M. R. F., Miller, K. A., Alvi, M., Goos, J. A. C., Lees, M. M., de Burca, A., Henderson, A., Kraus, A., Mikat, B., Vries, B. B. A. D., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.04.014 · Cited by 48
Synapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders
Parra‐Damas, A., & Saura, C. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.006 · Cited by 48
Schulmann, A., Ryu, E., Gonçalves, V. F., Rollins, B. L., Christiansen, M., Frye, M. A., Biernacka, J. M., & Vawter, M. P. (2019) · Complex Psychiatry · doi:10.1159/000495658 · Cited by 48
KALRN: A central regulator of synaptic function and synaptopathies
Parnell, E., Shapiro, L. P., Voorn, R. A., Forrest, M. P., Jalloul, H. A., Loizzo, D. D., & Penzes, P. (2020) · Gene · doi:10.1016/j.gene.2020.145306 · Cited by 48
Mancini, M., Bassani, S., & Passafaro, M. (2020) · Cells · doi:10.3390/cells9122711 · Cited by 48
Metadata
- Authors
- Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., Carrera, N., Humphreys, I., Johnson, J. S., Roussos, P., Barker, D. D., Banks, E., Milanova, V., Grant, S. G., Hannon, E., Rose, S. A., Chambert, K., Mahajan, M., Scolnick, E. M., Moran, J. L., Kirov, G., Palotie, A., McCarroll, S. A., Holmans, P., Sklar, P., Owen, M. J., Purcell, S. M., & O’Donovan, M. C.
- Affiliations
- Broad Institute (US)
- Cardiff University (GB)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- Medical University of Sofia (BG)
- University of Edinburgh (GB)
- Corresponding author
- Owen, Michael J.
- ORCID
- Fromer, Menachem
- Pocklington, Andrew J.
- Williams, Hywel J.
- Dwyer, Sarah
- Gormley, Padhraig
- Rees, Elliott
- Palta, Priit
- Ruderfer, Douglas M.
- Carrera, Noa
- Johnson, Jessica S.
- Roussos, Panos
- Banks, Eric
- Milanova, Vihra
- Grant, Seth G.
- Hannon, Eilis
- Rose, Samuel A.
- Scolnick, Edward M.
- Moran, Jennifer L.
- Kirov, George
- Palotie, Aarno
- McCarroll, Steven A.
- Holmans, Peter
- Sklar, Pamela
- Owen, Michael J.
- Purcell, Shaun M.
- O’Donovan, Michael C.
- Venue
- Nature
- Published
- 2014-01-22
- Volume
- 506
- Issue
- 7487
- Pages
- 179-184
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4237002
- OpenAlex
- W2023962370
- Cited by
- 1,617
- References
- 43
- Citations by year
- 2026: 39 · 2025: 68 · 2024: 64 · 2023: 91 · 2022: 114 · 2021: 134 · 2020: 127 · 2019: 168 · 2018: 149 · 2017: 193 · 2016: 186 · 2015: 164 · 2014: 120
- FWCI
- 168.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01BX002395)
- Wellcome Trust (089062, WT 098051, WT089062, 098051)
- Medical Research Council (MR/L010305/1)
- National Institute of Mental Health (P50MH066392, R01MH071681, R01MH099126)
- National Human Genome Research Institute (R01HG005827)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- schizophrenia, de novo mutations, synaptic proteins, glutamatergic synapses, activity-regulated cytoskeleton-associated protein, NMDA receptor, FMRP, actin filament dynamics, autism spectrum disorder, intellectual disability, neurodevelopmental disorders, synaptic efficacy
- MeSH terms
- Child Development Disorders, Pervasive, Cytoskeletal Proteins, Humans, Intellectual Disability, Models, Neurological, Mutation, Nerve Net, Nerve Tissue Proteins, Neural Pathways, Phenotype, RNA, Messenger, Schizophrenia, Substrate Specificity, Synapses, Receptors, N-Methyl-D-Aspartate, Fragile X Messenger Ribonucleoprotein 1, Exome, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
